You may also like
Blood Component Recalls and Market Withdrawals: Frequency, Reasons, and Management in the United States
The U.S. Food and Drug Administration has issued several recent guidances that address transfusion service actions for dealing with specific infectious disease problems. This present article updates our 2004 recommendations as to when to notify physicians about transfused nonconforming blood components.